Jimenez Rivera JJ, Iribarren JL, Raya JM, Nassar I, Lorente L, Perez R, Brouard M, Lorenzo JM, Garrido P, Barrios Y, Diaz M, Alarco B, Martinez R, Mora ML: Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case–control study. J Cardiothorac Surg. 2007, 2: 17-10.1186/1749-8090-2-17.
Article
PubMed
PubMed Central
Google Scholar
Sniecinski RM, Chandler WL: Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg. 2011, 113: 1319-1333. 10.1213/ANE.0b013e3182354b7e.
Article
PubMed
Google Scholar
Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ, Quinn RD, Nugent WC, Birkmeyer JD, O'Connor GT: Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg. 1998, 133: 442-447. 10.1001/archsurg.133.4.442.
Article
CAS
PubMed
Google Scholar
Iribarren JL, Jimenez JJ, Hernandez D, Brouard M, Riverol D, Lorente L, de La Llana R, Nassar I, Perez R, Martinez R, Mora ML: Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene. Anesthesiology. 2008, 108: 596-602. 10.1097/ALN.0b013e318167aecc.
Article
CAS
PubMed
Google Scholar
Kuepper F, Dangas G, Mueller-Chorus A, Kulka PM, Zenz M, Wiebalck A: Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy. Blood Coagul Fibrinolysis. 2003, 14: 147-153. 10.1097/00001721-200302000-00005.
Article
CAS
PubMed
Google Scholar
Burzotta F, Iacoviello L, Di Castelnuovo A, Zamparelli R, D'Orazio A, Amore C, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F: 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study. J Thromb Thrombolysis. 2003, 16: 149-154.
Article
CAS
PubMed
Google Scholar
Vaughan DE: Angiotensin, fibrinolysis, and vascular homeostasis. Am J Cardiol. 2001, 87: 18C-24C. 10.1016/S0002-9149(01)01509-0.
Article
CAS
PubMed
Google Scholar
Mehta R, Shapiro AD: Plasminogen activator inhibitor type 1 deficiency. Haemophilia. 2008, 14: 1255-1260. 10.1111/j.1365-2516.2008.01834.x.
Article
CAS
PubMed
Google Scholar
Kruithof EK: Plasminogen activator inhibitors–a review. Enzyme. 1988, 40: 113-121.
CAS
PubMed
Google Scholar
Chandler WL, Levy WC, Stratton JR: The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. Circulation. 1995, 92: 2984-2994. 10.1161/01.CIR.92.10.2984.
Article
CAS
PubMed
Google Scholar
Yavari M, Becker RC: Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. J Thromb Thrombolysis. 2009, 27: 95-104. 10.1007/s11239-007-0187-5.
Article
PubMed
Google Scholar
Paulitsch FS, Schneider D, Sobel BE, Rached R, Ramires J, Jatene F, Stolf N, Hueb W, Lopes NH: Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study. Coron Artery Dis. 2009, 20: 100-105. 10.1097/MCA.0b013e3283219e8b.
Article
PubMed
Google Scholar
Untch BR, Jeske WP, Schwartz J, Botkin S, Prechel M, Walenga JM, Bakhos M: Inflammatory and hemostatic activation in patients undergoing off-pump coronary artery bypass grafting. Clin Appl Thromb Hemost. 2008, 14: 141-148. 10.1177/1076029607308869.
Article
PubMed
Google Scholar
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999, 16: 9-13. 10.1016/S1010-7940(99)00134-7.
Article
CAS
PubMed
Google Scholar
Clauss A: Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 1957, 17: 237-246. 10.1159/000205234.
Article
CAS
PubMed
Google Scholar
Chandler WL, Fitch JC, Wall MH, Verrier ED, Cochran RP, Soltow LO, Spiess D: Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost. 1995, 74: 1293-1297.
CAS
PubMed
Google Scholar
Sirgo G, Morales P, Rello J: PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery–pilot study. Eur J Anaesthesiol. 2009, 26: 404-411. 10.1097/EJA.0b013e3283240412.
Article
CAS
PubMed
Google Scholar
Welsby IJ, Podgoreanu MV, Phillips-Bute B, Mathew JP, Smith PK, Newman MF, Schwinn DA, Stafford-Smith M, Perioperative G, Safety Outcomes Study Investigative T: Genetic factors contribute to bleeding after cardiac surgery. J Thromb Haemost. 2005, 3: 1206-1212. 10.1111/j.1538-7836.2005.01337.x.
Article
CAS
PubMed
Google Scholar
Duggan E, O'Dwyer MJ, Caraher E, Diviney D, McGovern E, Kelleher D, McManus R, Ryan T: Coagulopathy after cardiac surgery may be influenced by a functional plasminogen activator inhibitor polymorphism. Anesth Analg. 2007, 104: 1343-1347. 10.1213/01.ane.0000261267.28891.00. table of contents
Article
CAS
PubMed
Google Scholar
Dawson S, Hamsten A, Wiman B, Henney A, Humphries S: Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb. 1991, 11: 183-190. 10.1161/01.ATV.11.1.183.
Article
CAS
PubMed
Google Scholar
DeLoughery TG: Coagulation defects in trauma patients: etiology, recognition, and therapy. Crit Care Clin. 2004, 20: 13-24. 10.1016/S0749-0704(03)00089-7.
Article
PubMed
Google Scholar
Gaudino M, Zamparelli R, Andreotti F, Burzotta F, Iacoviello L, Glieca F, Benedett M, Maseri A, Schiavello R, Possati G: Normothermia does not improve postoperative hemostasis nor does it reduce inflammatory activation in patients undergoing primary isolated coronary artery bypass. J Thorac Cardiovasc Surg. 2002, 123: 1092-1100. 10.1067/mtc.2002.120709.
Article
PubMed
Google Scholar
Chandler W: The effects of cardiopulmonary bypass on fibrin formation and lysis: is a normal fibrinolytic response essential?. J Cardiovasc Pharmacol. 1996, 27 (Suppl 1): S63-S68.
Article
CAS
PubMed
Google Scholar
Agren A, Kolmert T, Wiman B, Schulman S: Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate. Thromb Res. 2007, 119: 715-721. 10.1016/j.thromres.2006.06.014.
Article
CAS
PubMed
Google Scholar
Jankun J, Keck R, Selman SH, Skrzypczak-Jankun E: Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss. Int J Mol Med. 2010, 26: 501-504.
CAS
PubMed
Google Scholar
D'Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM: Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest. 1985, 15: 308-312. 10.1111/j.1365-2362.1985.tb00277.x.
Article
PubMed
Google Scholar
Mannucci L, Gerometta PS, Mussoni L, Antona C, Parolari A, Salvi L, Biglioli P, Tremoli E: One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin. Thromb Haemost. 1995, 73: 356-361.
CAS
PubMed
Google Scholar
Nuttall GA, Henderson N, Quinn M, Blair C, Summers L, Williams BA, Oliver WC, Santrach PJ: Excessive bleeding and transfusion in a prior cardiac surgery is associated with excessive bleeding and transfusion in the next surgery. Anesth Analg. 2006, 102: 1012-1017. 10.1213/01.ane.0000198563.28246.00.
Article
PubMed
Google Scholar
Engles L: Review and application of serine protease inhibition in coronary artery bypass graft surgery. Am J Health Syst Pharm. 2005, 62: S9-S14. 10.2146/ajhp050300.
Article
CAS
PubMed
Google Scholar
Edmunds LH: Managing fibrinolysis without aprotinin. Ann Thorac Surg. 2010, 89: 324-331. 10.1016/j.athoracsur.2009.10.043.
Article
PubMed
Google Scholar